MRI-Guided Neurosurgical Ablation Market Size Worth US$ 5.4 Bn by 2026 Print E-mail
By GLOBE NEWSWIRE   
Tuesday, 13 August 2019 05:00

LOS ANGELES, Aug. 13, 2019 (GLOBE NEWSWIRE)

LOS ANGELES, Aug. 13, 2019 (GLOBE NEWSWIRE) -- The global MRI-guided neurosurgical ablation market is estimated to grow at CAGR above 4.3 % over the forecast time frame 2019 to 2026 and reach the market value around US$ 5.4 billion by 2026.

Free Download Sample Report Pages for Better [email protected] https://www.acumenresearchandconsulting.com/request-sample/1554

An increased incidence of brain tumors and other diseases of the nervous system and an increased use of minimally invasive neurosurgeries are some of the variables that will increase development.

An increasing amount of brain tumor patients is one of the growth factors. Tumors of the brain can also spread to other brain sites (secondary or metastatic). There is a separate therapy, biology and prognosis for every form of disease. Similarly, brain cancer also has some threat variables owing to unusual cell development. The National Health Institutes (NIH) projected that 1,65,813 individuals in the United States lived with brain cancer in 2016 and, in 2019, that 17,760 individuals are predicted to die from brain cancer.

Advances in technology are also anticipated to support business development. For example, Medtronic has developed a laser ablation device guided by Visualase MRI that monitors tissues ablation in real time. The lowest laser catheter is 1.65 mm in diameter, resulting in a narrower incision that helps patients heal more quickly. It utilizes laser technology to kill smooth tissues unwanted. The amount of minimally invasive processes is therefore anticipated to increase to support development.

View Detail Information with Complete [email protected] https://www.acumenresearchandconsulting.com/mri-guided-neurosurgical-ablation-market

In 2018, North America dominated the industry with its highest business share. During its reign as a prediction, North America is anticipated to remain leading the industry as minimally invasive operations are increasing and cancer in the region is increasing. Moreover, APEJ nations, Japan and China are rapidly increasing areas for MRI-led neurosurgical ablation. Different main producers on the market invest heavily in these areas. In the worldwide MRI-led neurophragic ablation industry, slower development is anticipated in the Middle East, Africa and Latin America due to a shortage of medical practitioners and a absence of knowledge of MRI-guided neurosurgery across these areas.

Key Findings

  • In 2018, the section of accessories dominated the industry. This can be ascribed to the growing amount of brain tumor patients accompanied by benign tumors.
  • In 2018, the hospital segment dominated the market with the highest share of the malignant tumors and increase of the geriatric population in the central nervous system.
  • In 2018, North America dominated the neurosurgical ablation industry with the largest income margin due to a growing consciousness of minimally invasive neurosurgics and the accessibility of qualified neurosurgers.

Browse all official Market Research Reports Press [email protected] https://www.acumenresearchandconsulting.com/press-releases

Explore Our Market [email protected] https://www.acumenresearchandconsulting.com/blogs

Key Players & Strategies

INSIGHTEC Ltd., Medtronic plc, Monteris Medical, Inc. and MRI Interventions, Inc. are among the main competitors working on the market. The games will concentrate on the introduction of fresh Neurosurgical Ablation systems and equipment for IRM, technological progress and policies for development, such as fusions and purchases. For example, in May 2015, Monteris Medical announced a NeuroBlate system which uses MRI-guided surgical ablation technics for the treatment of brain disorders as a minimally invasive laser thermotherapy. These progresses are expected to boost development during the prediction era.

Innovation and collaboration are two main strategies accompanied by neurosurgical ablation led by MRI manufacturers. MRI Guided Neurosurgical Ablation's leading company focuses on cooperation to encourage the use of MRI Guided Neurosurgical Ablation for brain tumor therapy. Some businesses work straight with clinics to support their MRI Guided Neurosurgical ablation scheme. On the other side, few competitors on the MRI Guided Neurosurgical Ablation industry emphasize cooperation with retailers in order to increase their global existence.

Acumen Research and Consulting Enters Partnership with MARKETWATCH, Click Here

Request for [email protected] https://www.acumenresearchandconsulting.com/request-customization/1554

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report - https://www.acumenresearchandconsulting.com/buy-now/0/1554

If you would like to place an order or have any questions, please feel free to contact at [email protected]

| +1 407 915 4157 OR +1 408 900 9135

For Latest Update Follow Us:

https://twitter.com/AcumenRC

https://www.facebook.com/acumenresearchandconsulting

https://www.linkedin.com/company/acumen-research-and-consulting/ 


Primary Logo




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter